New heart balloon shows promise in artery opening trial

NCT ID NCT05509296

First seen Apr 01, 2026 · Last updated Jun 19, 2026 · Updated 12 times

Summary

This study tested a new balloon catheter called SINOMED CBC for treating narrowed coronary arteries. It involved 136 patients with stable or unstable angina or evidence of heart muscle ischemia. The device was compared to a standard balloon catheter to see if it was as safe and effective at opening blockages during angioplasty.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IN-STENT RESTENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Kaifeng Central Hospital

    Kaifeng, China

  • Peking University First Hospital

    Beijing, China

  • Peking University Third Hospital

    Beijing, China

  • The First People's Hospital of Lianyungang

    Lianyungang, China

  • Tianjin Chest Hospital

    Tianjin, China

  • Tianjin Forth Central Hospital

    Tianjin, China

  • Wuxi People's Hospital

    Wuxi, China

  • Xuzhou cancer hospital

    Xuzhou, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

cutting balloon catheter (SINOMED CBC)

What this could lead to

If successful, this device could offer a safe and effective alternative for opening blocked heart arteries during angioplasty.

What could go wrong

This is a small, completed non-inferiority trial, so it only shows the device is not worse than the standard. Long-term benefits or risks are not yet known.

Conditions

The condition(s) this trial relates to.

coronary restenosis coronary stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.